Catalyst Wire Dossier Catalyst Wire Dossier

LAT8881

· Lateral Pharma Pty Ltd
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for LAT8881, covering 2021-03-30 to 2024-11-27. Get the full timeline:

Most recent: Clinical Trial Update: A Two-part Proof-of-Concept Study Assessing the Safety and Efficacy of LAT8881 in Lumbar Radicular Pain [Phase 1]

See pricing